Nemaura Medical (NMRD) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free NMRD Stock Alerts $0.04 +0.01 (+28.57%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comComparing Pulse Biosciences (NASDAQ:PLSE) & Nemaura Medical (NASDAQ:NMRD)February 23, 2024 | benzinga.comNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning CallsJanuary 22, 2024 | finance.yahoo.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 3, 2024 | finanznachrichten.deNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finance.yahoo.comImportant Update on Listing Status and Strategic DirectionDecember 20, 2023 | markets.businessinsider.comBuy Rating Affirmed for Nemaura Medical on sugarBEAT Prospects and Market ExpansionDecember 13, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finance.yahoo.comNemaura Medical Inc. Receives Positive Nasdaq Listing DecisionNovember 27, 2023 | msn.comNemaura Medical (NMRD) Price Target Increased by 54.55% to 8.67November 21, 2023 | finance.yahoo.comNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthNovember 17, 2023 | msn.comNemaura (NMRD) to Expand in UK With Metabolic Health ProgramNovember 16, 2023 | finance.yahoo.comNemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)November 15, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateNovember 14, 2023 | seekingalpha.comAcutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2MNovember 14, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 14, 2023 | finance.yahoo.comNemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 13, 2023 | finance.yahoo.comNemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateOctober 18, 2023 | msn.comSeaStar Medical gets FDA breakthrough status for cytokine storm deviceSeptember 26, 2023 | finance.yahoo.comNemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.September 18, 2023 | finance.yahoo.comNemaura Medical to Present at the Maxim Group Emerging Growth in A.I. ConferenceSeptember 16, 2023 | seekingalpha.comNemaura Medical says compliance regain with Nasdaq rules not expectedSeptember 14, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Provides Update on Nasdaq Compliance Status and ProcessSeptember 14, 2023 | finance.yahoo.comNemaura Medical Provides Update on Nasdaq Compliance Status and ProcessSeptember 14, 2023 | benzinga.comTop Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)September 13, 2023 | finance.yahoo.comNemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss ProgramSeptember 12, 2023 | finance.yahoo.comNemaura Medical Announces Participation at HLTH 2023, Las VegasSeptember 11, 2023 | finance.yahoo.comNemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim ResultsAugust 23, 2023 | finance.yahoo.comNemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?August 21, 2023 | msn.comHC Wainwright & Co. Maintains Nemaura Medical (NMRD) Buy RecommendationAugust 21, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Nemaura Medical (NMRD), Kineta (KA) and Regeneron (REGN)August 17, 2023 | finance.yahoo.comNemaura Medical Announces SFDA Approval of sugarBEAT®August 14, 2023 | finance.yahoo.comNemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business UpdateAugust 11, 2023 | finance.yahoo.comNemaura Medical Secures $6.5m in Non-Dilutive FundingAugust 3, 2023 | msn.comNemaura Medical (NMRD) Price Target Decreased by 8.70% to 7.14July 17, 2023 | msn.comEF Hutton Maintains Nemaura Medical (NMRD) Buy RecommendationJuly 14, 2023 | fool.comNemaura Medical (NASDAQ: NMRD)July 14, 2023 | finance.yahoo.comNemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023June 27, 2023 | finance.yahoo.comNemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023June 22, 2023 | finance.yahoo.comNemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023June 15, 2023 | finance.yahoo.comNemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023June 1, 2023 | benzinga.comNemaura Medical Stock (NASDAQ:NMRD), Insider Trading ActivityMarch 21, 2023 | finance.yahoo.comNemaura Medical to Participate in Fireside Chat Hosted by EF HuttonMarch 15, 2023 | finance.yahoo.comNemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License AgreementMarch 9, 2023 | finance.yahoo.comNemaura Medical Announces Receipt of Notice from NasdaqFebruary 24, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business UpdateFebruary 24, 2023 | finance.yahoo.comNemaura Medical, Inc. (NMRD) Reports Q3 Loss, Lags Revenue EstimatesFebruary 24, 2023 | finance.yahoo.comNemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business UpdateFebruary 16, 2023 | finance.yahoo.comNemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual ConferenceJanuary 31, 2023 | finance.yahoo.comNemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private PlacementJanuary 27, 2023 | finance.yahoo.comNemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. NMRD Media Mentions By Week NMRD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NMRD News Sentiment▼0.000.54▲Average Medical News Sentiment NMRD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NMRD Articles This Week▼10▲NMRD Articles Average Week Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BJDX News Today SINT News Today MOTS News Today RSLS News Today DYNT News Today INVO News Today QNRX News Today TNON News Today IONM News Today AEMD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NMRD) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.